Cargando…
Correction to: YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma
Autores principales: | Kuo, Yi-Zih, Kang, Ya-Rong, Chang, Wei-Lun, Sim, Lydia Chin Ling, Hsieh, Tzu-Chin, Chang, Chu-Han, Wang, Yi-Ching, Tsai, Ching-Jung, Huang, Li-Chun, Tsai, Sen-Tien, Wu, Li-Wha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579075/ https://www.ncbi.nlm.nih.gov/pubmed/36223034 http://dx.doi.org/10.1007/s13402-022-00721-5 |
Ejemplares similares
-
YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma
por: Kuo, Yi-Zih, et al.
Publicado: (2022) -
Clinical significance of YAP1 and TAZ in esophageal squamous cell carcinoma
por: Liu, Li, et al.
Publicado: (2021) -
WIP-YAP/TAZ as A New Pro-Oncogenic Pathway in Glioma
por: Rivas, Sergio, et al.
Publicado: (2018) -
Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous
Melanoma
por: Nallet-Staub, Flore, et al.
Publicado: (2014) -
Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)